Maintenance of the Hematopoietic Stem Cell Niche Monocytes and Macrophages

描述（由申请人提供）：造血干细胞和祖细胞（HSPC）动员到外周血中使得骨髓（BM）移植的供体细胞收获更加方便，并提高了细胞产量和植入。通过G-CSF（非格司亭）的HSPC动员是通过调节干细胞龛介导的，干细胞龛是保留和调节HSPC的BM微环境。在文献中有许多提示，单核细胞和巨噬细胞控制造血生态位。本申请提出研究表达M-CSF受体（CD 115）的细胞在维持HSC小生境中的作用。我们的初步数据表明，G-CSF减少了BM单核细胞和巨噬细胞的数量，这些群体的体内消耗与HSPC动员和BM CXCL 12（一种HSPC滞留趋化因子）的减少相关。在该提议中，1将a）在另外两个CD 115+细胞耗竭的体内模型中证实这种相关性，B）鉴定介导串扰的因子（通过与鼠BM衍生的基质细胞系共培养的CD 115+细胞的微阵列和培养上清液的蛋白质阵列），c）确定CDI 15消耗诱导的HSPC动员对交感神经系统的依赖性（使用交感神经切除术的药理学、手术和遗传模型），和d）阐明这种动员与其他动员剂（G-CSF和AMD 3100）的协同作用。对于目标a、c、d、e，本人将通过集落形成试验评估HSPC动员，通过流式细胞术评估CD 115+细胞减少，通过ELISA评估CXCL 12趋化因子减少。公共卫生相关性：虽然干细胞动员使移植用供体细胞的回收更加方便和有效，但在高达40%的患者中，干细胞数量不足。所提出的实验可能导致靶向BM单核细胞和巨噬细胞以最大化干细胞产量的新策略的开发。该项目的结果也对非造血干细胞龛的维持具有广泛的影响，其操作可以有助于促进损伤后的组织修复，如心肌梗死，创伤性烧伤和神经退行性变。

DESCRIPTION (provided by applicant): Mobilization of hematopoietic stem and progenitor cells (HSPCs) into the peripheral blood has made harvest of donor cells for bone marrow (BM) transplantations more convenient and improved cell yield and engraftment. HSPC mobilization by G-CSF (Filgrastim) is mediated by modulation of the stem cell niche, which is the BM microenvironment that retains and regulates HSPCs. There have been many hints in the literature that monocytes and macrophages control the hematopoietic niche. This application proposes to study the role of the M-CSF receptor (CD115)-expressing cells in the maintenance of the HSC niche. Our preliminary data indicates that G-CSF reduces BM monocyte and macrophage numbers and in vivo depletion of these populations is correlated with HSPC mobilization and reduction in BM CXCL12, an HSPC retention chemokine. In this proposal, 1 will a) confirm this correlation in two additional in vivo models of CD115+ cell depletion, b) identify the factors mediating cross-talk (via microarray of CD115+ cells co-cultured with a murine BM-derived stromal cell line and protein array of culture supernatant), c) determine dependence of CDI 15-depletion-induced mobilization of HSPC on the sympathetic nervous system (using pharmacological, surgical and genetic models of sympathectomy), and d) elucidate synergy of this mobilization with other mobilizing agents (G-CSF and AMD3100). For aims a, c, d, e, I will assess HSPC mobilization by colony forming assays, CD115+ cell reduction by flow cytometry, and reduction in CXCL12 chemokine by ELISA. PUBLIC HEALTH RELEVANCE: While stem cell mobilization has made retrieval of donor cells for transplants more convenient and efficient, it yields an insufficient number of stem cells in up to 40% of patients. The experiments proposed can potentially lead to the development of new strategies targeting the BM monocytes and macrophages to maximize stem cell yield. The results of this project also has broad implications for the maintenance of non-hematopoietic stem cell niches, whose manipulation can be instrumental in facilitating tissue repair after injuries, such as myocardial infarction, traumatic burns, and neurodegeneration.